Search Menu
Photonics Media Photonics Buyers' Guide Photonics Spectra BioPhotonics EuroPhotonics Vision Spectra Photonics Showcase Photonics ProdSpec Photonics Handbook
More News

Fluoptics Opens Massachusetts Office

Facebook Twitter LinkedIn Email Comments
GRENOBLE, France, and CAMBRIDGE, Mass., April 25, 2012 — To market and sell its solutions for preclinical in vivo fluorescence imaging, France-based Fluoptics announced it has opened an office in Cambridge.

Fluoptics develops integrated solutions that combine a nonradioactive fluorescent tracer targeting cancer cells with its Fluobeam real-time optical imaging system. The proprietary device, due to enter clinical trials this year in Europe, is already available to the preclinical research market. More than 15 units have been sold worldwide.

“We will now work on accelerating the distribution of our preclinical instruments in the US and Canada directly or through key partnerships,” said Odile Allard, CEO of Fluoptics.

Fluobeam is already used with small and large animals in preclinical trials in fields such as drug development, cancer, inflammation, and infectious and cardiovascular diseases.

Once approved for the clinical market, the technology will help surgeons see what the naked eye cannot. It will illuminate cancer cells in real time for the surgeon performing the resection of cancerous tumors using natural light, for example.

Fluoptics develops fluorescence image-guided surgery equipment.

For more information, visit:
Apr 2012
The technology of generating and harnessing light and other forms of radiant energy whose quantum unit is the photon. The science includes light emission, transmission, deflection, amplification and detection by optical components and instruments, lasers and other light sources, fiber optics, electro-optical instrumentation, related hardware and electronics, and sophisticated systems. The range of applications of photonics extends from energy generation to detection to communications and...
AmericasBiophotonicsBusinesscancer cell illuminationCancer Cellscancerous tumorscardiovascular imagingclinical trialsdrug developmentEuropeFluobeamFluopticsfluorescence image-guided surgeryfluorescence imagingFranceimagingMassachusettsnonradioactive fluorescent tracerOdile Allardoptical imaging systemphotonicspreclinical trials

back to top
Facebook Twitter Instagram LinkedIn YouTube RSS
©2020 Photonics Media, 100 West St., Pittsfield, MA, 01201 USA, [email protected]

Photonics Media, Laurin Publishing
x We deliver – right to your inbox. Subscribe FREE to our newsletters.
We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.